Nature's Sunshine Products NATR Immunity — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Nature's Sunshine Products in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Nature's Sunshine Products’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nature's Sunshine Products's immunity — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Nature's Sunshine Products's immunity — net sales?
- Nature's Sunshine Products (NATR) reported immunity — net sales of $10.15M in Q1 2026.
- How has Nature's Sunshine Products's immunity — net sales changed year-over-year?
- Nature's Sunshine Products's immunity — net sales decreased by 1.3% year-over-year, from $10.28M to $10.15M.
- What is the long-term trend for Nature's Sunshine Products's immunity — net sales?
- Over 4 years (2021 to 2025), Nature's Sunshine Products's immunity — net sales has grown at a 5.6% compound annual growth rate (CAGR), from $32.79M to $40.82M.
- What does immunity — net sales mean?
- This metric represents the total revenue generated from the sale of nutritional and wellness products specifically formulated to support immune system health. It serves as a key indicator of consumer demand for the company's immunity-focused product portfolio and reflects the segment's contribution to overall corporate top-line performance. Tracking this figure helps investors assess the growth trajectory and market penetration of the company's health-oriented product categories.